Earnings Report

Trump, earnings and SCOTUS. Here’s what’s On Our Radar today:

Trump, earnings and SCOTUS. Here’s what’s On Our Radar today:

Exxon Mobil Corp, the world's largest publicly traded oil producer, posted a better-than-expected quarterly profit on Tuesday helped by rising crude prices and lower costs.

Exxon Mobil Corp, the world's largest publicly traded oil producer, posted a better-than-expected quarterly profit on Tuesday helped by rising crude prices and lower costs.

Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.

Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.

United Parcel reported an adjusted 4Q profit of $1.63 per share, missing the estimate for $1.69. Revenue for the package delivery company came in at $16.93 billion. The estimate was for $17 billion.

United Parcel reported an adjusted 4Q profit of $1.63 per share, missing the estimate for $1.69. Revenue for the package delivery company came in at $16.93 billion. The estimate was for $17 billion.

Sprint reported a 3Q loss of $0.12 per share, coming in larger than the estimate for a loss of $0.09. Revenue for the company came in at $8.55 billion, beating the estimate for $8.28 billion.

Sprint reported a 3Q loss of $0.12 per share, coming in larger than the estimate for a loss of $0.09. Revenue for the company came in at $8.55 billion, beating the estimate for $8.28 billion.

Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.

Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.

Eli Lilly reported a 7.2 percent rise in quarterly revenue, lifted by higher demand for its diabetes drug Trulicity and other new treatments.

Eli Lilly reported a 7.2 percent rise in quarterly revenue, lifted by higher demand for its diabetes drug Trulicity and other new treatments.

Health insurer Aetna, whose $34 billion deal for Humana was blocked last week, reported a higher-than-expected quarterly profit on Tuesday, helped by higher premiums for its plans.

Health insurer Aetna, whose $34 billion deal for Humana was blocked last week, reported a higher-than-expected quarterly profit on Tuesday, helped by higher premiums for its plans.

Japanese video game maker Nintendo Co. is reporting third quarter profit more than doubled from a year earlier on healthy sales of Pokemon game software.

Japanese video game maker Nintendo Co. is reporting third quarter profit more than doubled from a year earlier on healthy sales of Pokemon game software.

The S&P 500 and the Dow were set for their worst day in more than three months on Monday as investors worried over President Donald Trump's orders to restrict travel to the United States.